Application 022348

Type
NDA
Sponsor
CUMBERLAND PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001CALDOLORIBUPROFENSOLUTION;INTRAVENOUS400MG/4ML (100MG/ML)NoNo
002CALDOLORIBUPROFENSOLUTION;INTRAVENOUS800MG/8ML (100MG/ML)YesYes
003CALDOLORIBUPROFENSOLUTION;INTRAVENOUS800MG/200ML (4MG/ML)YesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
66220-284CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-284CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-284CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-287CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-287CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-287CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-287CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent
66220-287CaldoloribuprofenCumberland Pharmaceuticals Inc.NDACurrent

Documents

DocumentSubmission typeDate
84846SUPPL 2026-01-28
84834SUPPL 2026-01-26
80390SUPPL 2024-11-25
80308SUPPL 2024-11-22
74232SUPPL 2023-05-12
72828SUPPL2022-12-08
72814SUPPL2022-12-07
69386SUPPL2021-11-23
69364SUPPL2021-11-22
67333SUPPL2021-05-03
67274SUPPL2021-04-30
59424SUPPL2019-07-23
59418SUPPL2019-07-23
38607SUPPL2016-05-11
29633SUPPL2016-05-11
17280SUPPL2015-11-25
7278SUPPL2015-11-23
7277SUPPL2015-01-28
42496ORIG2010-03-11
24286ORIG2010-03-11
38606ORIG2009-06-22
29632ORIG2009-06-17
51171SUPPL1900-01-01
51170SUPPL1900-01-01
51169SUPPL1900-01-01
51168SUPPL1900-01-01